Protein synthesis as a target for antibacterial drugs: current status and future opportunities

Bibliography

• KUCKERS A, MCKBENNETT N: The Use of Antibiotics(Fourth Edition). Heinmann Medical, Oxford (1987).
   Google Scholar
• GALE EF, CUNDLIFFE E, REYNOLDS PE, RICHMOND MH,WARING MJ: The Molecular Basis of Antibiotic Action (First Edition). John Wiley (Ed.), London (1972).
   Google Scholar
• •Contains a useful summary of early biochemical studies on protein synthesis inhibitors.
   Google Scholar
• ALBERTS B, BRAY D, LEWIS J et al: Molecular Biology of the Cell (Third Edition). Garland Publishing, New York (1994).
   Google Scholar
• KROON AM, VAN DEN BOGERT C: Antibacterial drugs and their interference with the biogenesis of mito-chondria in animal and human cells. Pharm. Week. (1983) 5:81–87.
   Google Scholar
• CHOPRA I: Mode of action of the tetracyclines and thenature of bacterial resistance to them. In: The Tetracy-clines. Handbook of Experimental Pharmacology (Volume 78). Hlavka JJ, Boothe JH (Eds.), Springer-Verlag, Berlin, Germany (1985):317–392.
   Google Scholar
• GREEN R, NOLLER HF: Ribosomes and translation. Ann.Rev. Biochem. (1997) 66:679–716.
   PubMed Web of Science ®Google Scholar
• •Useful overview of recent studies on ribosomes and protein synthesis.
   Google Scholar
• MOAZED D, NOLLER HF: Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 327:389–394.
   PubMed Web of Science ®Google Scholar
• ••Important paper dealing with footprinting of inhibitors.
   Google Scholar
• CUNDLIFFE E: Recognition sites for antibiotics within rRNA. In: The Ribosome: Structure Function and Evolution. Hill WE et al. (Eds.), American Society for Microbiology, Washington, USA (1990):479–490.
   Google Scholar
• HAYES JD, WOLF CR: Molecular mechanisms of drug re-sistance. Biochem. J. (1990) 272:281–295.
   PubMed Web of Science ®Google Scholar
• RUSSELL AD, CHOPRA I: Understanding Antibacterial Ac-tion and Resistance (Second Edition). Ellis Horwood, Lon-don (1996).
   Google Scholar
• BOTTGER EC: Resistance to drugs targeting protein synthesis in mycobacteria. Trends Microbiol. (1994) 2:416–421.
   PubMedGoogle Scholar
• MORRIS S, BAI GH, SUFFYS P et al.: Molecular mecha-nisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. (1995) 171:954–960.
   PubMed Web of Science ®Google Scholar
• AMIKAM D, RAZIN S, GLASER G: Ribosomal RNA genes in mycoplasma. Nucl. Acids Res. (1982) 10:4215–4222.
   PubMed Web of Science ®Google Scholar
• ENGEL JN, GANEM D: Chlamydial rRNA operons: gene organization and identification of putative random promotors. j Bacteriol. (1987) 169:5678–5685.
   PubMed Web of Science ®Google Scholar
• CHOPRA I, HAWKEY PM, HINTON M: Tetracyclines, mo-lecular and clinical aspects. J. Antimicrob. Chemother. (1992) 29:245–277.
   PubMed Web of Science ®Google Scholar
• ROBERTS MC: Tetracycline resistance determinants: mechanisms of action, regulation of expression, ge-netic mobility and distribution. FEMS Microbic]. Rev. (1996) 19:1–24.
   PubMed Web of Science ®Google Scholar
• TESTA RT, PETERSON PJ, JACOBUS NV et al: In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob. Agents Chemother. (1993) 37:2270–2277.
   PubMed Web of Science ®Google Scholar
• CHOPRA I: Glycylcyclines - third generation tetracy-cline analogues. Exp. Opin. Invest. Drugs (1994) 3:191–193.
   Google Scholar
• •Useful mini-review on the glycylcyclines.
   Google Scholar
• TALLY FT, ELLESTAD GA, TESTA RT: Glycylcyclines: a new generation of tetracyclines. J. Antimicrob. Chemo-ther. (1995) 35:449–452.
   PubMed Web of Science ®Google Scholar
• •Useful mini-review on the glycylcyclines.
   Google Scholar
• WEISS WJ, PETERSON PJ: The postantibiotic effect of the glycylcyclines, DMG-MINO and DMG-DMDOT. 37th In-terscience Conference on Antimicrobial Agents and Chemo-therapy Toronto, Canada. Am. Soc. Microbiol (1997). Abstract F–53.
   Google Scholar
• KIRST HA, SIDES GD: New directions for macrolide anti-biotics: structural modifications and in vitro activity. Antimicrob. Agents Chemother. (1989) 33:1413–1418.
   PubMed Web of Science ®Google Scholar
• KIRST HA, SIDES GD: New directions for macrolide anti-biotics: pharmacokinetics and clinical efficacy. Anti-microb. Agents Chemother. (1989) 33:1419–1422.
   PubMed Web of Science ®Google Scholar
• JAYNES BH, DIRLAM JP, HECKER SJ: Antibacterial agents. Ann. Rep. Med. Chem. (1996) 31:121–130.
   Web of Science ®Google Scholar
• GRIESGRABER G, OR SY, CHU DTW et al.: 3-keto-11, 12-carbazate derivatives of 6-0-methylerythromycin A. Synthesis and in vitro activity. J. Antibiotics (1996) 49:465–477.
   PubMed Web of Science ®Google Scholar
• SCHULIN T, WENNERSTEN CB, MOELLERING RC, ELIO-POULOS GM: In vitro activity of RU6004, a new ketolide antibiotic, against Gram-positive bacteria. Antimicrob. Agents Chemother. (1997) 41:1196–1202.
   PubMed Web of Science ®Google Scholar
• ZURENKO GW, FORD CW, HUTCHINSON DK, BRICKNER SJ, BARBACHYN MR: Oxazolidinone antibacterial agents: development of the clinical candidates epere-zolid and linezolid. Exp. Opin. Invest. Drugs (1997) 6:151–158.
   PubMedGoogle Scholar
• •Useful mini-review on the oxazolidiones.
   Google Scholar
• FORD CW, HAMEL J C, STAPERT D et al.: Oxazolidinones: new antibacterial agents. Trends Microbiol. (1997) 5:196–200.
   PubMed Web of Science ®Google Scholar
• •Useful mini-review on the oxazolidiones.
   Google Scholar
• BARBACHYN MR, HUTCHINSON DK, BRICKNER SJ et al: Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. (1996) 39:680–685.
   PubMed Web of Science ®Google Scholar
• SHINABARGER DL, MAROTTI KR, MURRAY RW et al: Mechanism of action of oxazolidinones: effects of line-zolid and eperezolid on translation reactions. Antimi-crob. Agents Chemother. (1997) 41:2132–2136.
   PubMed Web of Science ®Google Scholar
• BURGHARDT H, SCHIMZ K-L, MULLER M: On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria. FEBS Lett. (1998) 425:40–44.
   PubMed Web of Science ®Google Scholar
• J. Antimicrob. Chemother. (1997) 39. (Suppl. A) (Entire vol- ume.)
   Google Scholar
• ••An important collection of papers detailing the nature andproperties of Synercid.
   Google Scholar
• NICCOLAI D, TARSI L, THOMAS RJ: The renewed chal-lenge of antibacterial chemotherapy. Chem. Commun. (1997):2333–2342.
   Web of Science ®Google Scholar
• VANNUFFEL P, DI GIAMBATTISTA M, COCITO C: The roleof rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J. Biol. Chem. (1992) 267:16114–16120.
   PubMed Web of Science ®Google Scholar
• SELVA E, GASTALDO L, SADDLER GS et al.: Antibiotics A21459 and B, new inhibitors of bacterial protein syn-thesis. I. Taxonomy, isolation and characterization. J. Antibiotics (1996) 49:145–149.
   Google Scholar
• HAYASHI SF, NORCIA LJL, SEIBEL SB et al: Structure-activity relationships of hygromycin A and its analogs: protein synthesis inhibition activity in a cell free sys-tem. J. Antibiotics (1997) 50:514–521.
   PubMed Web of Science ®Google Scholar